Table 5.
Within-person association between moments of negative mood or perceived stress and deceleration capacity of heart rate averaged in the hour prior the corresponding EMA prompt.
Overall | Women | Men | |
---|---|---|---|
Percent difference (95% CI) in ln DC per 20-unit increase in momentary negative mood score | |||
Unadjusted | −1.8 (−3.0, −0.5) | −2.2 (−3.9, −0.4) | −1.3 (−3.1, 0.5) |
Adjusted for sociodemographic factors* | −1.4 (−2.5, −0.4) | −1.8 (−3.3, −0.3) | −1.2 (−2.7, 0.4) |
Adjusted for the above plus CAD risk factors† | −1.3 (−2.2, −0.3) | −1.6 (−2.9, −0.3) | −1.0 (−2.4, 0.5) |
Adjusted for the above plus psychosocial scales‡ and antidepressant medication use | −1.2 (−2.1, −0.2) | −1.6 (−2.9, −0.3) | −0.7 (−2.1, 0.7) |
Adjusted for the above plus CAD severity¶ | −1.4 (−2.5, −0.3) | −1.9 (−3.4, −0.3) | −0.9 (−2.6, 0.7) |
Adjusted for the above plus cardiovascular medications ⊠ | −1.5 (−2.7, −0.4) | −2.2 (−3.8, −0.6) | −0.9 (−2.3, 0.8) |
Percent difference (95% CI) in ln DC comparing moments with stress to moments with no stress | |||
Unadjusted | −2.5 (−4.5, −0.6) | −2.0 (−5.1, 1.0) | −2.9 (−5.5, −0.3) |
Adjusted for sociodemographic factors* | −2.2 (−3.9, −0.5) | −1.8 (−4.4, 0.9) | −2.6 (−5.0, −0.3) |
Adjusted for the above plus CAD risk factors† | −2.0 (−3.5, −0.4) | −1.7 (−4.1, 0.7) | −2.4 (−4.5, −0.2) |
Adjusted for the above plus psychosocial scales‡ and antidepressant medication use | −1.9 (−3.4, −0.4) | −1.8 (−4.1, 0.5) | −2.1 (−4.1, 0.01) |
Adjusted for the above plus CAD severity¶ | −2.2 (−4.0, −0.5) | −2.1 (−4.8, 0.5) | −2.5 (−4.9, −0.1) |
Adjusted for the above plus cardiovascular medications⊠ | −2.3 (−4.1, −0.6) | −2.3 (−4.9, 0.4) | −2.5 (−4.9, −0.1) |
CI: confidence interval; DC: deceleration capacity; CAD: coronary artery disease.
Age, sex (in overall models), race (black versus non-black), married, education > 12 years.
Ever smoking, BMI, history of hypertension and diabetes mellitus.
Beck Depression Inventory score, and PTSD Symptom Checklist score at the clinic visit.
Left ventricular ejection fraction, Gensini CAD severity score, ST-segment elevation MI.
Beta-blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and statins.